欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0318/002
药品名称Clarithromycin Sandoz 50 mg/ml
活性成分
    • clarithromycin 50.0 mg/ml
剂型Granules for oral suspension
上市许可持有人Sandoz GmbH Biochemiestrasse 10 6250 Kundl AUSTRIA
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Germany (DE)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Clarithromycin Sandoz 250 mg/5 ml - Granulat für orale Suspension
    • Spain (ES)
许可日期2004/07/22
最近更新日期2014/12/15
药物ATC编码
    • J01FA09 clarithromycin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Article 4.8(a)(iii), first paragraph
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase